Extension Study of Oral ELND005 in Patients with Alzheimer’s Disease

• Research type

  Research Study

• Full title

  A 36-Week Safety Extension Study of Oral ELND005 for Treatment of Agitation and Aggression in Patients With Moderate to Severe Alzheimer’s Disease

• IRAS ID

  126906

• Contact name

  Roy Jones

• Sponsor organisation

  Elan Pharma International Limited

• Eudract number

  2012-005524-15

• Clinicaltrials.gov Identifier

  NCT01766336

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  13/SC/0285

• Date of REC Opinion

  3 Sep 2013

• REC opinion

  Further Information Favourable Opinion